Skip to main content
Signal8
Launch Terminal

Protagenic Therapeutics, Inc.\new (PTIX)

Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Protagenic Therapeutics, Inc. logo

Protagenic Therapeutics, Inc.

OTC:PTIXHealthcare
-10.02%$0.6478
Mkt Cap$1.17M
Float1.25M
O/S1.81M
Inst Own3.7%
SI1.0%
Dilution
Protagenic Therapeutics, Inc. logoOTC:PTIX$0.6478-10.02%
FormDescription
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
8-K
7.01,8.01,9.01
4
4
Statement of Changes in Beneficial Ownership
10-Q
Quarterly Report
10
NT 10-Q
SEC Filing
3
10-K
Annual Report
6
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
NT 10-K
SEC Filing
2
8-K
5.02
10-Q
Quarterly Report
8-K
5.02
8-K
1.01,1.02,2.01,3.02,8.01,9.01
NT 10-Q
SEC Filing
25-NSE
SEC Filing
8-K
3.01
DEF 14A
Definitive Proxy Statement
10-Q
Quarterly Report
8-K
3.01,7.01,9.01
NT 10-Q
SEC Filing
8-K
5.02
8-K
8.01,9.01

1-25 of 705

…